Amended and Restated At Market Issuance Sales AgreementCardiome Pharma Corp • March 7th, 2016 • Pharmaceutical preparations • New York
Cardiome Pharma Corp. (the “Company”), a corporation formed under the Canada Business Corporations Act (the “CBCA”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) and MLV & Co. LLC (“MLV”, each of FBR and MLV, individually a “Distribution Agent”, and collectively, the “Distribution Agents”), to amend and restate the At Market Issuance Sales Agreement dated February 18, 2014 between the Company and MLV, as follows:
